H CUSABIO
LIVE

Add to watchlist:

No watchlists yet
View on USPTO

H CUSABIO Trademark

Serial Number: 79382663 • Registration: 7636826

H CUSABIO is a trademark filed by WUHAN HUAMEI BIOTECH CO., LTD. on May 19, 2023. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus), Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

WUHAN HUAMEI BIOTECH CO., LTD. (3 trademarks)

Building B11,

Entity Type: 99

Trademark Details

Filing Date

May 19, 2023

Registration Date

January 7, 2025

Published for Opposition

November 19, 2024

Goods & Services

Research and development of new products for others; technological research in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies, namely, conducting scientific project feasibility studies; conducting technical project studies in the field of biotechnology, antigens, proteins, antibodies, microorganisms, cells, bioscience and immunology; conducting technical project studies in the field of custom design and development of chemical reagents and biochemical assays; scientific laboratory services; cosmetic research; chemical analysis; chemistry services, namely, consultation in the field of chemistry, research and development services in the field of immunocytochemistry, chemical and biomolecular analysis, research in the fields of chemistry and biochemistry, chemical research laboratory services, consultancy in the field of biochemistry, research and development services in the field of biochemistry; chemical research; biological research; bacteriological research

Apparatus for artificial respiration; Medical apparatus and instrument for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testing, cytology and cell-based testing; breath gas analyzers for medical diagnostics; medical diagnostic instruments for the analysis of body fluids; medical instruments for analysing and identifying bacteria; Medical apparatus and instruments, namely, flow cytometers and flow-based analyzers providing cell and particle analysis, detection, or counting for medical, clinical, medical diagnostic, and therapeutic uses; Diagnostic kits consisting primarily of probes, buffers and reagents for use in microbial testing for medical purposes; dental apparatus, electric; galvanic therapeutic appliances; beds specially made for medical purposes; feeding bottles; orthopedic articles, namely, orthopedic braces; suture materials

Protein in raw material form for scientific and medical research; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for scientific purposes, other than for medical or veterinary use; test paper, chemical; chemical reagents, other than for medical or veterinary purposes; preparations of microorganisms, other than for medical and veterinary use; bacterial preparations, other than for medical and veterinary use; diagnostic preparations, other than for medical or veterinary purposes; plant growth regulating preparations

Antibiotics for human use; Vaccines for human use; Medicinal preparations for the treatment of infectious diseases and for use in oncology; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; enzyme preparations for medical purposes; pharmaceutical preparations, namely, antibody drugs for the treatment of cancer, tumors, anti-rejection of organ transplantation; pharmaceutical preparations for the treatment of tumors, cancer and infectious diseases, namely, antibodies, antibody derivatives, antibody-drug conjugates for medical purposes; chemical preparations for the diagnosis of pregnancy; medicinal drinks; chemical preparations for pharmaceutical purposes, namely, chemical reagents; injectable medicinal solutions, namely, injectable pharmaceuticals for the treatment and prevention of cancer, autoimmune and inflammatory diseases, rheumatoid arthritis, cardiovascular diseases and infectious diseases; dietetic substances adapted for medical use, namely, dietetic preparations, protein dietary supplements; antiseptics

Filing History

FINAL DECISION TRANSACTION PROCESSED BY IB
Jul 26, 2025 FINO
FINAL DISPOSITION NOTICE SENT TO IB
Jul 4, 2025 FICS
FINAL DISPOSITION PROCESSED
Jul 4, 2025 FIMP
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
Apr 26, 2025 OPNX
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Apr 8, 2025 OPNS
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
Apr 8, 2025 OPNR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Apr 7, 2025 FICR
NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jan 7, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jan 7, 2025 R.PR
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Nov 19, 2024 NPUB
PUBLISHED FOR OPPOSITION
Nov 19, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 13, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Oct 9, 2024 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 4, 2024 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 4, 2024 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 4, 2024 TROA
NEW REPRESENTATIVE AT IB RECEIVED
Jun 10, 2024 NREP
REFUSAL PROCESSED BY IB
Apr 8, 2024 RFNT
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Mar 20, 2024 RFCS
REFUSAL PROCESSED BY MPU
Mar 20, 2024 RFRR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Feb 29, 2024 RFCR
NON-FINAL ACTION WRITTEN
Feb 28, 2024 CNRT
ASSIGNED TO EXAMINER
Feb 13, 2024 DOCK
APPLICATION FILING RECEIPT MAILED
Nov 17, 2023 MAFR
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 13, 2023 NWOS
SN ASSIGNED FOR SECT 66A APPL FROM IB
Nov 9, 2023 REPR